WPWashington Post·1hHealth
score+0.85
FDA approves ‘landmark’ pancreatic cancer drug that extends patients’ lives
Original
FDA approves ‘landmark’ pancreatic cancer drug that extends patients’ lives
“Strong positive valence driven by 'landmark' approval and significant survival extension for a fatal disease.”